Researchers have discovered a new way of developing painkillers that act only on inflamed tissues, while keeping healthy ones unaffected, suggesting that the severe side effects currently associated with these medicines might be avoided.
When used in an animal model, their prototype of a morphine-like molecule was able to produce substantial pain relief in inflamed tissues without severe side effects, according to a study published in the journal Science.
The team of researchers used computational simulation to analyse interactions at opioid receptors -- the cell's docking sites for painkillers.
"By analysing drug-opioid receptor interactions in damaged tissues, as opposed to healthy tissues, we were hoping to provide useful information for the design of new painkillers without harmful side effects," said Christoph Stein from Charite - Universitatsmedizin Berlin in Germany.
Opioids are a class of strong pain killers and are mainly used to treat pain associated with tissue damage and inflammation, such as that caused by surgery, nerve damage, arthritis or cancer.
Common side effects associated with their use include drowsiness, nausea, constipation and dependency and, in some cases, respiratory arrest.
In this study, the the researchers showed that they were able to analyse morphine-like molecules and their interactions with opioid receptors.
They were able to successfully identify a new mechanism of action, which is capable of producing pain relief only in the desired target tissues -- those affected by inflammation.
The new findings could lead to treating postoperative and chronic inflammatory pain without causing side effects.
Doing so would substantially improve patient quality of life.
--IANS
gb/vm
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
